Back

Anticoagulant therapy in patients with atrial fibrillation and diabetic or non-diabetic chronic kidney disease

19 April 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Arrhythmias and device therapy Atrial Fibrillation, Other EAPC Premium Access EuroPrevent 2018

About the speaker

Photo
Doctor Irina Daaboul

I.M. Sechenov First Moscow State Medical University, Moscow (Russian Federation)

5 More presentations in this session

Presentation thumbnail
Arrhythmias and device therapy - Poster discussant:
Presentation thumbnail
The quality of life in patients with paroxysmal atrial fibrillation after catheter ablation
Professor N. Pogosova (Moscow, RU)
Abstract
Presentation thumbnail
De novo atrial arrhythmia after isolated surgical aortic valve replacement
Assistant Professor Y. Hwang (Suwon, KR)
Abstract
Presentation thumbnail
Design of the FRAIL-AF study: safety of switching anticoagulant management (from VKA to NOAC) in frail elderly patients with atrial fibrillation: a randomised controlled trial
Ms L. Joosten (Utrecht, NL)
Abstract
Presentation thumbnail
Failure to anticoagulate patients with Atrial Fibrillation despite a high CHA2DS2Vasc score
Miss Y. Bashir (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Arrhythmias and device therapy

The Event

Event poster

EuroPrevent 2018

19 April - 21 April 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources